causa de internação foi a intoxicação digitálica. Vale aqui lembrar que a digoxina, que tem no idoso meia-vida aumentada e excreção reduzida, é considerada. taquiarritmias excluir a intoxicação digitálica ou hipokaliemia. (3) O risco de intoxicação digitálica é maior quando administrada por via. FAB se estiver disponível é a conduta de escolha em caso de arritmias malignas causadas por intoxicação digitálica. A toxicidade digitálica é precipitada pela.
|Published (Last):||15 May 2004|
|PDF File Size:||11.44 Mb|
|ePub File Size:||16.84 Mb|
|Price:||Free* [*Free Regsitration Required]|
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: Data from this work highlight the importance for intoxiccaao digoxin close monitoring during pharmacotherapy to guide its rational use and avoid digitalis intoxication. Adverse drug events resulting from patient errors in older adults.
According to the study of Kirimli et al. Long-term outcome of fulminante myocarditis as compared with acute non-fulminant myocarditis.
II Diretriz Brasileira de Insuficiência Cardíaca Aguda
Literature demonstrates a progressive increase in serum digoxin levels related to a decrease of digitalis renal clearance due to age Souza et al. Digoxin is not prescribed as an inotropic in acute HF. Bioavailability,pharmacokinetics, and pharmacodynamics of torsemide digitaica furosemide in patients with congestive heart failure. Admission B-type natriuretic peptide levels and in-hospital mortality acute decompensated heart failure.
itnoxicacao Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. Listing criteria for heart transplantation: Spironolactone in congestive heart failure refractory to high-dose loop diuretics and low-dose angiotensin-converting enzyme inhibitor.
Fluid responsiveness in spontaneously breathing patients: The physiologic basis of diuretic synergism: Undersdending and preventing drug interactions in elderly patients. Standards of laboratory practice: Significance of predischarge BNP on one-year outcome in decompensated heart failure: Differentiation at bedside by use of the simple Valsalva maneuver.
Eur Heart J A prospective, randomized study of goal-oriented hemodynamic therapy in cardiac surgical patients.
Polypharmacy: interaction and adverse reactions in the use of drugs by elderly people
Utility of impedance cardiography for the identification of short-term risk of clinical decompensation in stable intoxicaccao with chronic heart failure.
Vasodilators in the management of acute heart failure. Persistent orthopnea and the prognosis of patients in the heart failure clinic. Betablockers prolong life and reduce the risk of disease progression in patients with chronic HF.
Stevenson WG, Tedrow U. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. Yancy C, Abraham W. Remodeling of sinus node function in patients with congestive heart failure: Should we emergently revascularize occluded coronaries for cardiogenic shock.
As Cp interferes in the benefit related to digitalis, its measurement should be performed to ensure the maintenance of the levels within 0. The Digitalis Investigation Group. Patient selection and echocardiographic assessment of dyssynchrony in cardiac resynchronization therapy. A systematic review of the literature and the intoxicacwo of seven mares. Diuretics for heart failure. Evidence of improving prognosis in heart failure: Low pulse pressure is independently related to elevated natriuretic peptides and increased mortality in advanced chronic heart failure.
Racial and ethnic differences in the treatment and outcome of cardiogenic shock following acute myocardial infarction. A novel mechanism of heart failure with normal ejection fraction.
Controlled trial of oxygen in uncomplicated myocardial infarction. Implantable left ventricular assist devices. Combination of high-dose furosemide and hydrochlorothiazide in the treatment of refractory congestive heart failure.
Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure the LIDO study: The use of extracorporeal life support in adult patients intoxlcacao primary cardiac failure as a bridge to implantable left ventricular digitalicaa device.
The natural history of congestive heart failure: Levosimendan vs dobutamine for patients with acute decompensated heart failure: Curr Opin Crit Care.